← FDA DRUG APPROVALS

FDA ANDA · ANDA071961

NITROPRESS

Sponsor: VPNA

APPLICATION
ANDA071961
TYPE
ANDA
ORIGINAL APPROVAL
1988-08-01
LATEST ACTION
2014-01-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NITROPRESSDiscontinued
SODIUM NITROPRUSSIDE 25MG/ML · INJECTABLE · INJECTION

Approval history

2014-01-27Labeling · Supplement 13 · standard — Label ↗AP
1995-02-10Manufacturing (CMC) · Supplement 4 — Review ↗AP
1994-02-24Manufacturing (CMC) · Supplement 3 — Review ↗AP
1992-04-09Labeling · Supplement 2 — Review ↗AP
1991-01-29Labeling · Supplement 1AP
1988-08-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →